
May 14 (Reuters) - ARS Pharmaceuticals Inc SPRY.O:
ARS PHARMACEUTICALS Q1 OPERATING INCOME USD -37.177 MILLION VERSUS. IBES ESTIMATE USD -37.1 MILLION
ARS PHARMACEUTICALS Q1 OPERATING EXPENSES USD 45.15 MILLION
ARS PHARMACEUTICALS Q1 REVENUE USD 7.763 MILLION VERSUS. IBES ESTIMATE USD 7.48 MILLION
ARS PHARMACEUTICALS Q1 NET INCOME USD -33.94 MILLION VERSUS. IBES ESTIMATE USD -34.6 MILLION
ARS PHARMACEUTICALS Q1 BASIC EPS USD -0.35
ARS PHARMACEUTICALS Q1 CASH & INVESTMENTS USD 275.7 MILLION